Top Markets
#1 EXOD EXOD +56.80%
#2 MowCat MowCat +48.03%
#3 CoW Protocol CoW Protocol +41.64%
#4 Glidr Glidr +36.87%
#5 Humanity Humanity +23.75%
#6 Walrus Walrus +22.87%
#7 Enso Enso +21.16%
#8 Tutorial Tutorial +17.28%
#9 Codatta Codatta +16.14%
#10 Versatize Coin Versatize Coin +12.50%
Coin of the day
EXOD EXOD
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Lysogene S.A. Lysogene S.A.

Lysogene S.A.

LYS
Rang in Aktien #36618
Lysogene S.A. is a biopharmaceutical firm specializing in gene therapy,... Lysogene S.A. is a biopharmaceutical firm specializing in gene therapy, dedicated to discovering and advancing treatments for children affected by severe neurodegenerative lysosomal storage disorders. Its development pipeline includes LYS-SAF302, which is currently undergoing Phase II/III clinical trials for mucopolysaccharidosis type IIIA (MPS IIIA). Another promising candidate, LYS-GM101, is in Phase I/II development, targeting GM1 gangliosidosis. The company has also forged a research alliance with the Weizmann Institute of Science to pioneer novel adeno-associated virus (AAV) gene therapy approaches for conditions such as neuronopathic Gaucher disease, Parkinson's disease, and other related illnesses. Lysogene S.A. was established in 2009 and is headquartered in Neuilly-sur-Seine, France.
Aktienkurs
$0.30221445
Zuletzt synchronisiert: 2023-05-22
Marktkapitalisierung
$2.49M
Veränderung (1 Tag)
-0.10%
Veränderung (1 Jahr)
0.00%
Land
FR
Handel Lysogene S.A. (LYS)

Kategorie

Healthcare
EPS für Lysogene S.A. (LYS)
EPS zum 2026 TTM: 0
Laut den aktuellen Finanzberichten und dem Aktienkurs von Lysogene S.A. beträgt das aktuelle EPS des Unternehmens (TTM) 0. Am Ende des Jahres 2026 betrug das EPS 0 gleich wie dem EPS von 2026, das 0 betrug.
EPS-Verlauf von Lysogene S.A. von 2026 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
Nicht genügend Daten für die angegebenen Daten.
EPS für ähnliche Unternehmen oder Wettbewerber
Unternehmen EPS EPS-Differenz Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -
BE